Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK

Dec-07

Endocrinology Pharmacoepidemiology

AUTHORS : Dr Annalisa Rubino (Details for study: RTI Health Solutions), Astrazeneca, Cambridge, United Kingdom – Email: annalisa.rubino@astrazeneca.com

JOURNAL : Diabetic Medicine

REFERENCE: 24(12):1412-8

DOI : 10.1111/j.1464-5491.2007.02279.x

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more